Juan C. Jaen, President at Arcus Biosciences, Inc. (RCUS), sold 100,000 shares at $19.75 ($2.0M) on 2025-11-18, disclosed to the SEC on 2025-11-19.
Scheduled sale ($2.0M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.23 | 37,114 | $751K | 37.1% |
| 2 | $20.23 | 37,114 | $751K | 37.1% |
| 3 | $20.71 | 7,836 | $162K | 8.0% |
| 4 | $20.71 | 7,836 | $162K | 8.0% |
| 5 | $19.75 | 5,050 | $100K | 4.9% |
| 6 | $19.75 | 5,050 |
| $100K |
| 4.9% |
| Total | $20.26 avg | 100,000 | $2.0M | 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |